Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study
Bo Zhang,Xingya Li,Zhiyong Ma,Shucai Zhang,Xia Song,Hongjun Gao,Liqun Gong,Yi Hu,Mengzhao Wang,Da Jiang,Cuiying Zhang,Xuedong Yuan,Baoshan Cao,Peng Zhang,Ligong Nie,Yuhui Zhang,Xiaoyan Chen,Lei Han,Wenqiang Wei,Yuankai Shi
DOI: https://doi.org/10.1111/1759-7714.14444
IF: 3.223
2022-05-18
Thoracic Cancer
Abstract:We conducted a multicenter, cross‐sectional study in 18 hospitals across northern China to evaluate the prevalence and management of pain in lung cancer patients. Among the 533 patients surveyed, 45.4% (242/533) suffered pain in the course of their disease. Meanwhile, 24.2% (129/533) experienced pain within 24 h, only 74.4% (96/129) of whom were taking analgesics, suggesting inadequate treatment of cancer pain. There is still need for high‐quality pain education for patients and physicians. Background Pain is a fearful yet common symptom among lung cancer patients. This multicenter, cross‐sectional study was conducted to examine the current status of pain prevalence and management in lung cancer patients in northern China. Methods A total of 18 hospitals across northern China were selected. Patients with primary lung cancer who visited the outpatient clinic or were admitted in the wards on a preplanned day were invited to complete a questionnaire. Meanwhile, physicians who had experience of treating primary lung cancer patients were also surveyed. Results A total of 533 patients and 197 physicians provided valid responses to the survey, of which 45.4% (242/533) of patients reported pain during the course of disease and 24.2% (129/533) of patients had experienced pain within the past 24 h. The mean average pain intensity by the brief pain inventory was 3.47 ± 1.55. The binary logistic regression analysis showed female gender and stage IV disease were significantly associated with the presence of pain. A total of 74.4% (96/129) of patients reporting pain within 24 h were taking analgesics. The most common reason for patients not using analgesics was that the pain was tolerable (48.2%), while the most common barriers to prescribing opioids as reported by physicians were fear of adverse reactions (43.7%) and fear of addiction (43.1%). Conclusion Despite recognition of the importance of pain control by most physicians and an improvement in cancer pain management, inadequate treatment of cancer pain still exists in lung cancer patients in northern China. High‐quality pain education for both patients and physicians is needed in the future.
oncology,respiratory system